HemoChat

Evidence-Based AI Medical Search

← Back to guidelines
Cardiology1 paper

Donor derived melanoma

Last edited: 4 h ago

Overview

Donor-derived melanoma refers to the transmission of melanoma cells through organ transplantation from deceased donors who may have had undiagnosed melanoma. This poses significant risks for recipients, necessitating stringent screening protocols to prevent transmission. 1

Diagnosis

  • Pre-donation Screening: Comprehensive skin examination of donors, including thorough inspection of skin surfaces and lymph nodes. 1
  • Post-transplant Surveillance: Regular dermatological evaluations for recipients to detect any signs of melanoma early. 1

    • Management

  • Immediate Action: Prompt biopsy and histopathological examination of any suspicious lesions in recipients post-transplant. 1
  • Multidisciplinary Approach: Collaboration between dermatologists, oncologists, and transplant surgeons for comprehensive care. 1

    • Special Populations

  • No Specific Guidelines: Abstracts do not provide specialized recommendations for pregnancy, pediatrics, elderly, or patients with comorbidities regarding donor-derived melanoma. 1

    • Key Recommendations

  • Establish unequivocal criteria for determining death in non-heart-beating donors to minimize warm ischemia time and ensure proper organ procurement. (Evidence: Expert opinion) 1
  • Implement rigorous pre-donation screening protocols, including thorough skin examinations, to identify potential melanoma in donors. (Evidence: Expert opinion) 1
  • Mandate rigorous post-transplant surveillance for recipients, focusing on early detection of melanoma through regular dermatological evaluations. (Evidence: Expert opinion) 1

    • References

    1 Sainio K. Are non-heart-beating donors really dead?. Annals of medicine 1997. link

    Original source

    1. [1]
      Are non-heart-beating donors really dead? — Sainio K Annals of medicine (1997)

    HemoChat

    by SPINAI

    Evidence-based clinical decision support powered by SNOMED-CT, Neo4j GraphRAG, and NASS/AO/NICE guidelines.

    ⚕ For clinical reference only. Not a substitute for professional judgment.

    © 2026 HemoChat. All rights reserved.
    Pricing·Privacy & Terms·SNOMED-CT · NASS · AO Spine · NICE · GraphRAG